5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptid
ATIC
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN973587
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für 5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC) Peptid (ABIN973587)
Target
ATIC
(5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ATIC antibody (Catalog #: ARP46094_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ATIC (5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
-
Hintergrund
-
ATIC is a bifunctional protein requiring dimerization for transformylase activity.
Alias Symbols: AICAR, AICARFT, FLJ93545, IMPCHASE, PURH
Protein Interaction Partner: ATIC,CMBL,ELF3,HNRPDL,IKBKE,JAK1,NDUFAF1,NME2,PSTPIP1,RADIL,SNRPA,STOM
Protein Size: 281 -
Molekulargewicht
- 30 kDa
-
Gen-ID
- 471
-
NCBI Accession
- NM_004044
-
UniProt
- P31939
Target
-
Sie sind hier:
